Michigan hospital merger threatens jobs and patient services

Ella Castle

After University of Michigan Health System’s acquisition of Sparrow Health became official last month, questions continue to mount on how the deal will impact workers and patients. While UM Health is tight-lipped on the details of this impact, the general answers to these questions are already well known. As it […]

After University of Michigan Health System’s acquisition of Sparrow Health became official last month, questions continue to mount on how the deal will impact workers and patients. While UM Health is tight-lipped on the details of this impact, the general answers to these questions are already well known.

As it always happens in mergers, UM Health will begin ruthless cost-cutting and consolidation of operations. While job cuts will begin with eliminating redundancies in business functions, this merger will mean cuts all down the line. In locations where UM Health and Sparrow each have facilities, one will close, or the two will be combined, with workers fired to avoid duplication.

Sparrow Health was already a health system in decline. Tax records from 2020 and 2021 show net operating losses of $24 million, then $67.7 million, while their un-audited income statement from 2022 shows a loss of $172 million. 

UM Health’s decision to acquire Sparrow is not a public-spirited attempt to prop up an ailing health system. Despite its semi-public status as the medical unit of a huge state university, UM Health is behaving toward Sparrow exactly like any profit-making corporation swallowing up a smaller competitor.

When UM Health first announced the plan to acquire Sparrow in December 2022, they emphasized the prediction that this would make Michigan Medicine a $7 billion organization.

Aside from the predicted increase in net worth, UM Health also has reason to think the merger will substantially increase their market share in the state. The industry group Michigan Health and Hospital Association (MHHA) estimated, based on 2021 data from the Michigan Inpatient Database, that UM Health’s market share could increase to 11 percent. 

Like any company under capitalism, UM Health’s interest in Sparrow is strictly monetary.

The term “not-for-profit” does not indicate a charitable mission but merely a tax status. Brian Peters, CEO of MHHA, put this into perspective in an interview with Bridge Michigan. “The ultimate goal of any organization–whether it’s a hospital system or any other entity in the community–is not about maintaining your independence. It’s about maintaining your viability.”

While UM Health has not said how it will make Sparrow “viable,” the only way to realize their goals is by slashing wages, cutting jobs, combining offices and facilities, and taking advantage of the combined system’s near-monopoly in much of central Michigan to raise prices. This has already begun to happen,.

Next Post

FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

The FDA has approved the Pfizer’s nirmatrelvir tablets and ritonavir tablets, co-packaged as Paxlovid, for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for disease progression to severe COVID-19, including hospital or death. This marks the fourth drug, and first oral antiviral pill, approved by the […]
FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

Subscribe US Now

situs judi bola Daftar sekarang dengan cara klik link login slot via dana 24 jam terpercaya, join sekarang slot gacor online dengan pilihan platform game slot pragmatic play paling favorit tahun 2023. akun pro thailand idn poker